The week in health tech, explained in plain English.Get the free newsletter →
October 5, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Payers

Why Insurers Want Agentic AI as Connective Tissue

Health insurers have spent years accumulating software: claims engines, prior authorization tools, member service platforms, and analytics systems. The problem, according to Healthcare Dive, is that these investments rarely talk to each other, leaving data and workflows fragmented across the organization.

The pitch for agentic AI is different from the usual point solution. Instead of adding another isolated tool, agentic systems are designed to act as connective tissue, with AI agents coordinating tasks across the systems insurers already own. In practice, that means an agent could pull data from multiple platforms, trigger actions, and move a process forward without a human stitching each step together by hand.

For payers, the appeal is operational. Administrative complexity drives cost, and orchestration promises to reduce manual handoffs across functions like claims and authorizations. The open question is execution: whether agentic AI can reliably coordinate legacy systems at scale, and whether insurers can govern autonomous agents making decisions that affect members.

More in Payers

Payers

7 Health System Insurers to Exit Medicare Advantage in 2027

Seven health system-owned insurers are among 11 health plans exiting the individual Medicare Advantage market in 2027, with several others narrowing to special needs plans only.

Why it matters: The exits signal that even provider-owned plans are struggling with Medicare Advantage economics, forcing seniors to find new coverage.

Payers

CMS Projects Lower MA Premiums, Flat Enrollment for 2027

CMS projects lower average Medicare Advantage premiums and flat enrollment of 34 million for 2027, a figure that already trails current membership of 36.1 million.

Why it matters: Medicare Advantage now covers nearly half of all Medicare enrollees, so its premium and growth trajectory shapes revenue for insurers, providers, and the federal budget.

Payers

PBMs Become Rare Bipartisan Target in Washington and States

A bipartisan push in Congress and statehouses aims to rein in pharmacy benefit managers, including proposals to force CVS and rivals to split their PBM and pharmacy businesses.

Why it matters: PBMs sit at the center of US drug pricing, and forced divestiture would upend the business models of the largest healthcare conglomerates.